Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Higgins John L
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,806,928    

Indirect Shares

   0      
Direct Value   $49,374,432    

Indirect Value

   $0      
Total Shares   2,806,928      
Total Value   $49,374,432      


Ligand Pharmaceuticals Inc $36,088,848 Techne Corp $2,957,560 OmniAb, Inc $10,328,024 Ligand Pharmaceuticals Inc $36,088,848 Techne Corp $2,957,560 OmniAb, Inc $10,328,024
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    11    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    6    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -34.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Director 2022-12-28 417,695 2007-02-01 0    Premium*  
            Techne Corp TECH Director 2024-05-14 36,608 2013-10-31 0    Premium*  
            OmniAb, Inc OABI Director 2024-01-30 2,352,625 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    165         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-08-30 4 S $258.25 $903,875 D/D (3,500) 85,419 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-01-10 4 OE $16.14 $545,371 D/D 33,790 119,209 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-01-23 4 D $111.78 $756,192 D/D (6,765) 126,090 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-01-23 4 A $0.00 $0 D/D 13,646 129,258 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-02-11 4 A $0.00 $0 D/D 12,809 138,899 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-02-15 4 D $120.86 $594,269 D/D (4,917) 133,982 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-03-13 4 B $114.29 $285,725 D/D 2,500 141,399 2.81 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-05-14 4 B $113.50 $283,750 D/D 2,500 143,899 2.81 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-05-31 4 B $108.20 $108,202 D/D 1,000 144,899 2.81 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-07-31 4 B $95.45 $176,583 D/D 1,850 146,749 2.81 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-12-20 4 A $0.00 $0 D/D 13,614 156,562 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-12-20 4 D $105.87 $714,517 D/D (6,749) 153,614 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-02-13 4 OE $9.96 $479,325 D/D 48,125 201,739 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-02-13 4 A $0.00 $0 D/D 13,559 210,289 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-02-13 4 D $95.68 $479,261 D/D (5,009) 196,730 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-02-15 4 D $97.23 $497,429 D/D (5,116) 205,173 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-07-07 4 OE $56.26 $302,098 D/D 4,315 204,571 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-11-09 4 D $81.77 $200,991 D/D (2,458) 222,113 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-11-09 4 OE $10.05 $201,000 D/D 20,000 224,571 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-12-08 4 OE $10.05 $147,303 D/D 14,657 236,770 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-12-08 4 D $87.52 $147,296 D/D (1,683) 235,087 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2020-12-31 4 A $84.53 $18,851 D/D 223 235,310 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-25 4 A $0.00 $0 D/D 15,553 248,018 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-25 4 AS $159.00 $7,950,000 D/D (50,000) 235,310 0 %
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-25 4 OE $14.47 $723,500 D/D 50,000 285,310 0 -
  165  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us